Cocrystal Pharma (COCP) Construction in Progress (2015 - 2016)
Cocrystal Pharma (COCP) reported Construction in Progress of $146.3 million for Q3 2016, little changed sequentially from $146.3 million in Q4 2015.
Cocrystal Pharma (COCP) Construction in Progress (2015 - 2016) Analysis & Trends
Cocrystal Pharma (COCP) has 2 years of Construction in Progress data on file, last reported at $146.3 million in Q3 2016.
- For the quarter ending Q3 2016, Construction in Progress changed N/A year-over-year to $146.3 million; the trailing twelve-month figure through Sep 2016 stood at $146.3 million (changed N/A YoY), and the FY2015 full-year result was $146.3 million, changed N/A from the prior year.
- Construction in Progress was little changed at $146.3 million in Q3 2016, from $146.3 million in the prior quarter.
- In the past five years, Construction in Progress ranged from a high of $146.3 million in Q4 2015 to a low of $146.3 million in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 137.45 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 146.30 Mn |
| Dec 31, 2015 | 146.30 Mn |